287 related articles for article (PubMed ID: 29378385)
21. A novel insertion in the FOXL2 gene in a Chilean patient with blepharophimosis ptosis epicanthus inversus syndrome type I.
Martinez-Aguayo A; Poggi H; Cattani A; Molina M; Romeo E; Lagos M
J Pediatr Endocrinol Metab; 2014 Jan; 27(1-2):181-4. PubMed ID: 24030029
[TBL] [Abstract][Full Text] [Related]
22. FOXL2 gene mutations and blepharophimosis-ptosis-epicanthus inversus syndrome (BPES): a novel mutation detected in a Chinese family and a statistic model for summarizing previous reported records.
Xu Y; Lei H; Dong H; Zhang L; Qin Q; Gao J; Zou Y; Yan X
Mutagenesis; 2009 Sep; 24(5):447-53. PubMed ID: 19592504
[TBL] [Abstract][Full Text] [Related]
23. Missense mutation outside the forkhead domain of FOXL2 causes a severe form of BPES type II.
Haghighi A; Verdin H; Haghighi-Kakhki H; Piri N; Gohari NS; De Baere E
Mol Vis; 2012; 18():211-8. PubMed ID: 22312189
[TBL] [Abstract][Full Text] [Related]
24. Blepharophimosis-ptosis-epicanthus inversus syndrome plus: deletion 3q22.3q23 in a patient with characteristic facial features and with genital anomalies, spastic diplegia, and speech delay.
Zahanova S; Meaney B; Łabieniec B; Verdin H; De Baere E; Nowaczyk MJM
Clin Dysmorphol; 2012 Jan; 21(1):48-52. PubMed ID: 21934608
[TBL] [Abstract][Full Text] [Related]
25. Co-occurrence of congenital hydronephrosis and FOXL2-associated blepharophimosis, ptosis, epicanthus inversus syndrome (BPES).
Gulati R; Verdin H; Halanaik D; Bhat BV; De Baere E
Eur J Med Genet; 2014 Oct; 57(10):576-8. PubMed ID: 25192944
[TBL] [Abstract][Full Text] [Related]
26. Deletion of cis-regulatory Element in FOXL2 Promoter in a Chinese Family of Type II Blepharophimosis-ptosis-epicanthus Inversus Syndrome with Polydactyly.
Shen Q; Zhao X; Ji Y; Chai P
J Craniofac Surg; 2024 Jan-Feb 01; 35(1):e52-e56. PubMed ID: 37938073
[TBL] [Abstract][Full Text] [Related]
27. Mutation spectrum of fork-head transcriptional factor gene (FOXL2) in Indian Blepharophimosis Ptosis Epicanthus Inversus Syndrome (BPES) patients.
Kaur I; Hussain A; Naik MN; Murthy R; Honavar SG
Br J Ophthalmol; 2011 Jun; 95(6):881-6. PubMed ID: 21325395
[TBL] [Abstract][Full Text] [Related]
28. Ovarian Reserve and ART Outcomes in Blepharophimosis-Ptosis-Epicanthus Inversus Syndrome Patients With
Meng T; Zhang W; Zhang R; Li J; Gao Y; Qin Y; Jiao X
Front Endocrinol (Lausanne); 2022; 13():829153. PubMed ID: 35574016
[TBL] [Abstract][Full Text] [Related]
29. A new FOXL2 gene mutation in a woman with premature ovarian failure and sporadic blepharophimosis-ptosis-epicanthus inversus syndrome.
Corrêa FJ; Tavares AB; Pereira RW; Abrão MS
Fertil Steril; 2010 Feb; 93(3):1006.e3-6. PubMed ID: 19969293
[TBL] [Abstract][Full Text] [Related]
30. Genetic analysis of the forkhead transcriptional factor 2 gene in three Chinese families with blepharophimosis syndrome.
Jiang H; Huang X; Su Z; Rao L; Wu S; Zhang T; Li K; Quan Q; Zhang K
Mol Vis; 2013; 19():418-23. PubMed ID: 23441113
[TBL] [Abstract][Full Text] [Related]
31. Genomic Disruption of
Niu BB; Tang N; Xu Q; Chai PW
Chin Med J (Engl); 2018 Oct; 131(19):2380-2383. PubMed ID: 30246734
[No Abstract] [Full Text] [Related]
32. Clinical and genetic studies of 17 Han Chinese pedigrees and 31 sporadic patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Wang Y; Wu Q; Cao W; Huang L; Liu W; Li C; Li N
Mol Vis; 2022; 28():352-358. PubMed ID: 36338666
[TBL] [Abstract][Full Text] [Related]
33. FOXL2 mutations in Taiwanese patients with blepharophimosis, ptosis, epicanthus inversus syndrome.
Lin WD; Chou IC; Lee NC; Wang CH; Hwu WL; Lin SP; Chao MC; Tsai Y; Tsai FJ
Clin Chem Lab Med; 2010 Apr; 48(4):485-8. PubMed ID: 20184535
[TBL] [Abstract][Full Text] [Related]
34. Blepharophimosis-ptosis-epicanthus inversus syndrome caused by a 54-kb microdeletion in a FOXL2 cis-regulatory element.
Bouman A; van Haelst M; van Spaendonk R
Clin Dysmorphol; 2018 Apr; 27(2):58-62. PubMed ID: 29481440
[No Abstract] [Full Text] [Related]
35. Genetic analysis of the FOXL2 gene using quantitative real-time PCR in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Hu S; Guo J; Wang B; Wang J; Zhou Z; Zhou G; Ding X; Ma X; Qi Y
Mol Vis; 2011 Feb; 17():436-42. PubMed ID: 21321671
[TBL] [Abstract][Full Text] [Related]
36. An individual with blepharophimosis-ptosis-epicanthus inversus syndrome (BPES) and additional features expands the phenotype associated with mutations in KAT6B.
Yu HC; Geiger EA; Medne L; Zackai EH; Shaikh TH
Am J Med Genet A; 2014 Apr; 164A(4):950-7. PubMed ID: 24458743
[TBL] [Abstract][Full Text] [Related]
37. Mutations of the transcription factor FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Li D; Zeng W; Tao J; Li S; Liang C; Chen X; Mu W; Wang X; Qin Y; Jie Y; Wei W
Genet Test Mol Biomarkers; 2009 Apr; 13(2):257-68. PubMed ID: 19371227
[TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of the FOXL2 gene in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Tang S; Wang X; Lin L; Sun Y; Wang Y; Yu H
Mutagenesis; 2006 Jan; 21(1):35-9. PubMed ID: 16394030
[TBL] [Abstract][Full Text] [Related]
39. FOXL2 mutations in Chinese patients with blepharophimosis-ptosis-epicanthus inversus syndrome.
Wang J; Liu J; Zhang Q
Mol Vis; 2007 Jan; 13():108-13. PubMed ID: 17277738
[TBL] [Abstract][Full Text] [Related]
40. [Analysis of FOXL2 gene mutation and genotype-phenotype correlation in a Chinese pedigree affected with blepharophimosis-ptosis-epicanthus inversus syndrome].
Cheng H; Wang T; Wang G; Wang J; Shen L; Han M; Yang S; Shi Y; Wang W; Li H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2018 Aug; 35(4):515-517. PubMed ID: 30098246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
